U
PCT Ltd PCTL
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

PCT Ltd is a U.S.-based technology and environmental services company focused on antimicrobial solutions, water treatment technologies, and disinfection systems. The company operates primarily in the environmental health, sanitation, and fluid management industries through proprietary chemistries and equipment platforms designed for commercial, industrial, agricultural, and healthcare-related applications. Its core business has historically centered on producing and distributing hypochlorous acid-based disinfectants and related fluid treatment systems intended to reduce pathogens and improve water quality.

The company’s principal revenue drivers have included equipment sales, recurring consumable chemical sales, water treatment services, and licensing or distribution arrangements tied to its technology platforms. PCT Ltd has evolved from a development-stage technology business into a commercially oriented operating company with interests in sanitation infrastructure and environmentally focused treatment systems. Public disclosures and market reporting indicate that the company has pursued a strategy built around proprietary intellectual property, recurring consumable demand, and long-term customer relationships in sectors requiring sanitation compliance and water management capabilities.

Business Operations

PCT Ltd conducts operations through business lines associated with antimicrobial fluids, water purification systems, and environmental treatment technologies. The company has referenced operations connected to Paradigm Convergence Technologies Corporation and related subsidiaries involved in manufacturing, distribution, and servicing activities. Revenue generation has generally come from the sale of treatment systems, recurring fluid or chemical supply contracts, maintenance arrangements, and technology deployment agreements. Public filings indicate activity in both domestic U.S. markets and selected international opportunities, though the scale of international operations appears limited relative to domestic operations.

The company’s operational model relies on proprietary formulations, treatment equipment, and service-based relationships tied to sanitation and water infrastructure. PCT Ltd has also disclosed partnerships and customer relationships involving commercial facilities, food production environments, healthcare-related applications, and industrial water treatment use cases. Certain operational details, including the scale of individual contracts and the long-term profitability of specific business units, are not consistently disclosed across public sources. Data inconclusive based on available public sources regarding the material contribution of some subsidiaries and joint ventures.

Strategic Position & Investments

PCT Ltd’s strategic direction has focused on expanding adoption of environmentally oriented disinfectant and water treatment technologies while building recurring revenue streams from consumable products and servicing agreements. Company disclosures have emphasized growth initiatives tied to water purification, pathogen control, agricultural applications, and large-scale fluid management systems. The company has also pursued commercialization of proprietary treatment technologies intended to reduce chemical waste and improve operational efficiency for customers operating in regulated sanitation environments.

Public filings and investor materials indicate that PCT Ltd has pursued acquisitions, technology licensing arrangements, and strategic partnerships to broaden its market reach. The company has highlighted investments in intellectual property development, manufacturing capability expansion, and deployment of treatment infrastructure. Its positioning has generally emphasized environmentally sustainable sanitation technologies and the increasing demand for water treatment and disinfection solutions across commercial and industrial sectors. However, publicly available information regarding the long-term financial performance of certain strategic investments remains limited, and some announced initiatives have not been independently verified as materially scaled operations.

Geographic Footprint

PCT Ltd is headquartered in the United States, with operations primarily concentrated in domestic markets. The company has reported business activity and customer relationships across multiple U.S. regions, particularly in sectors requiring water treatment and sanitation technologies. Its operational footprint has included manufacturing, servicing, and distribution activities tied to commercial and industrial customers.

The company has also referenced international business development efforts and distribution opportunities in regions outside the United States, including parts of North America, Europe, and other international markets through strategic relationships and channel partnerships. Available public information suggests that international exposure remains relatively modest compared with its U.S. business operations. Data inconclusive based on available public sources regarding the current scale of international revenue contribution.

Leadership & Governance

PCT Ltd is governed by an executive leadership team and board structure typical of publicly traded OTC market companies. Strategic leadership has emphasized technology commercialization, operational scaling, and development of recurring revenue opportunities tied to sanitation and water treatment infrastructure. Corporate communications and public filings indicate a focus on operational expansion, intellectual property development, and long-term adoption of the company’s environmental treatment technologies.

Key executives identified in public filings and company disclosures include:

  • Gary Grieco – Chief Executive Officer
  • Branko Barta – Chief Technology Officer
  • David R. Smith – Executive leadership and operational management roles referenced in public disclosures

Leadership composition and executive responsibilities have changed periodically over time, and some role assignments differ across filings and investor communications. Data inconclusive based on available public sources regarding the current status of certain historical executive positions and governance appointments.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $230.36
B
AAPL NASDAQ $319.97
B
AVGO NASDAQ $357.90
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $107.14
A
Top Financial Stocks
See All »
B
B
JPM NYSE $358.64
B
V NYSE $375.07
Top Health Care Stocks
See All »
B
LLY NYSE $1,149.36
B
JNJ NYSE $275.23
B
ABBV NYSE $256.46
Top Real Estate Stocks
See All »
B
PLD NYSE $137.34
B
EQIX NASDAQ $1,035.98